Recent Finacing
Recent Raise
Cambridge Epigenetix builds a genetic and epigenetic sequencing platform that detects five DNA letters including 5mC in a single workflow, integrating with existing sequencers for low-input blood/tissue assays.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Cambridge Epigenetix.
